How to File a Patent in Brazil with the Brazilian INPI: A Practical Guide for Foreign Businesses

Filing a patent in Brazil follows the familiar shape of preparing an application, requesting examination, and receiving a grant if the application clears. Two things tend to surprise foreign businesses. The first is that Brazil's national office, the Brazilian INPI (the Instituto Nacional da Propriedade Industrial, the national industrial property office), is a different body from the French INPI that shares the same initials; this guide concerns Brazil's office throughout. The second is that examination is not automatic: you must actively request it within a set period, and for pharmaceutical inventions a second regulator, the health agency ANVISA, also has a say. This guide walks through the national route and then sets it against the international alternatives, because route choice is one of the more important decisions a foreign business makes here. It is general information, not legal advice.

The specification, the claims and the drawings

A Brazilian patent application generally consists of a request to grant, a description of the invention full enough to enable a skilled person to carry it out, one or more claims that define the protection you are seeking, an abstract, and any drawings needed to understand the invention. The claims do the legal work. They mark the boundary of what you can later enforce, so their drafting is where most of the value and most of the risk sits. A description that discloses a clever invention but claims it narrowly leaves the substance unprotected, while claims that overreach invite objections during examination or vulnerability afterwards. This is craft work, and it is the main reason foreign applicants engage a qualified Brazilian patent agent or attorney rather than filing raw.

Brazil applies a strict approach to novelty. Any public disclosure before your filing date (or priority date, if you claim priority), whether you publish a paper, pitch to a manufacturer, exhibit at a trade fair or start selling, can undermine patentability. Brazilian law does provide a defined grace period for certain disclosures made by the inventor shortly before filing, but its exact length and the conditions that bring a disclosure within it are version-specific, so treat the duration as a range to confirm with the Brazilian INPI or local counsel rather than as a safety net. The defensive habit is simple: file before you disclose. If your invention is a more incremental technical improvement, Brazil also offers a utility model (the modelo de utilidade), a separate national right with its own requirements and term; we cover it in our guide to the Brazilian utility model, and the choice between a patent of invention and a utility model is one to make deliberately with local advice.

Portuguese-language filing and translation quality

The Brazilian INPI conducts proceedings in Portuguese, and the application documents are generally expected in Portuguese. It is sometimes possible to file in another language first and supply a Portuguese translation within a set period, but you should not rely on that as a default; confirm the current rule and the applicable deadline with the Brazilian INPI or a local representative before planning around it. Where translation is needed, treat its quality as a substantive issue, not an administrative one. A patent specification is a legal instrument, and a translation that subtly shifts the meaning of a claim term can narrow your protection or introduce ambiguity an examiner or a later challenger will exploit. Use a translator experienced in patent work and have the Portuguese claims reviewed by your Brazilian attorney rather than accepting a generalist rendering.

The local-representative requirement for foreign applicants

If you do not reside or have a place of business in Brazil, you will generally need to appoint a local representative qualified to act before the Brazilian INPI, with a power of attorney, to act for you and to receive correspondence. Treat representation as a structural requirement rather than an optional convenience, and build it into your timeline and budget from the outset. The same professional who handles your representation will usually draft or review the claims and manage the examination dialogue, so choosing well matters for the whole life of the application.

Requesting examination, publication and the backlog

Examination in Brazil is not triggered by filing. The applicant must file a separate request for examination, and pay the official fee, within a statutory period running from filing; miss it and the application can be treated as abandoned. The length of that period is set by the rules and is a deadline you cannot afford to misjudge, so confirm the current statutory period with the Brazilian INPI or local counsel and note it carefully rather than relying on memory.

The application is also published once a set period has elapsed after filing (or earlier on request), which publishes the technical disclosure. Publication may also give rise to certain rights on grant in respect of unauthorised exploitation in the intervening period, but the mechanics and enforceability of that are nuanced, so confirm the position with local counsel rather than assuming any automatic protection runs from publication. Examination then proceeds against the prior art for novelty, inventive step and the other patentability requirements, with one or more official communications raising objections; you respond within the deadlines the office sets. Brazil has historically been known for long patent pendency, a substantial examination backlog that could leave applications waiting years. The office has invested in reducing that backlog and pendency has been falling, but you should still plan for a longer timeline than in some other jurisdictions and treat any specific waiting time as confirm-with-the-office rather than fixed. One consequence worth flagging: a 2021 decision of the Brazilian Supreme Court (the STF, reportedly in ADI 5529) struck down the sole paragraph of Article 40 of the Industrial Property Law, which had guaranteed a minimum patent term to compensate for examination delay. The upshot is that you should not assume any automatic term extension for slow grant; confirm both the decision and how term is now calculated with local counsel rather than relying on this summary.

The ANVISA prior-consent step for pharmaceutical inventions

Pharmaceutical patent applications carry an extra layer that catches many foreign applicants out. In addition to the Brazilian INPI, applications relating to pharmaceutical products and processes generally require prior consent (the anuencia previa) from ANVISA, the national health surveillance agency, as part of the path to grant. This is a distinct administrative step with its own role and timing, and the precise scope of what falls within it, and how the INPI and ANVISA steps interact, have evolved over time and remain sensitive. If your invention touches pharmaceuticals, treat the ANVISA step as a planning item from the outset and read our dedicated guide to ANVISA prior consent, then confirm the current procedure with the Brazilian INPI, ANVISA or local counsel, because this is an area where the position has shifted and generic assumptions are unsafe.

Grant and keeping the patent in force

If the application clears examination, the Brazilian INPI grants the patent and publishes the grant. Grant is not the end of the cost. Annual maintenance fees (annuities) keep the right in force and are not tied to grant; in Brazil they generally run from a filing-date anniversary and can fall due even while the application is still pending. The precise schedule, when payment first falls due, and any grace period for late payment are version-specific. Missing one can cause the patent or application to lapse, after which the protection is gone. Official fees apply; confirm the current schedule and the current amount with the Brazilian INPI or local counsel. Note annuity due dates well ahead of time rather than relying on a single reminder. For the wider picture, see the patents in Brazil hub.

The PCT national phase and Paris priority

The national filing is only one way to reach protection in Brazil, and for many foreign businesses it is not the obvious one. Brazil is a member of the Patent Cooperation Treaty, so a single international application under the PCT secures an international filing date (and the benefit of any priority claim) recognised across the member states, and buys time, through an international phase, before you commit to protection in specific countries. You then enter the national phase, and for Brazil that means entering before the Brazilian INPI within the applicable national-phase deadline, with a Portuguese translation and a local representative in place. The national-phase deadline under the PCT is strict and forfeiting it is permanent, so confirm the applicable deadline before relying on it. For the wider mechanics, see our overview of the PCT route.

Where your home country is a Paris Convention or WTO member you can instead, or in addition, claim priority from an earlier foreign application if you file in Brazil within the priority period, which lets a first filing in your home country set the effective date for the Brazilian filing that follows; the length of that period is set by the rules, so confirm it rather than assuming. A further point worth noting for brand owners watching the wider Brazilian system: Brazil acceded to the Madrid Protocol relatively recently (reportedly with effect in 2019), which is a trade-mark mechanism rather than a patent one, so do not expect a Madrid-style single international filing to deliver a patent in Brazil; patents still come through the national, Paris or PCT routes described here. Brazil has also acceded to the Hague system for industrial designs (reportedly in force from 2023), which again concerns designs rather than patents; treat the design position cautiously, confirm the dates with an official source, and approach it as a separate topic.

A note before you file

IPEnvoy is not a law firm and does not provide legal advice; this is general information. The Brazilian system rewards early filing, careful claim drafting in Portuguese, a timely request for examination, attentive annuity management, and, for pharmaceutical inventions, early attention to the ANVISA prior-consent step. Before you file, confirm the current position with the Brazilian INPI's official website and a qualified local IP professional, who can pressure-test your route choice, your disclosure timing and the Portuguese wording of your claims against the facts of your invention.